
Qure.ai Hosts High-Impact Policy Roundtable at Constitution Club of India to Champion AI in Public Health
New Delhi [India], August 13: Qure.ai, a leading Indian deep-tech company and global healthcare AI pioneer, hosted a high-level roundtable on August 6 at the Constitution Club of India. The event brought together Members of Parliament, senior bureaucrats, public health leaders, and international development experts to discuss the role of artificial intelligence in strengthening India's public healthcare systems.
The roundtable focused on bringing to light the diverse challenges faced by India's public health system, as voiced by policymakers from across the country. Members of Parliament representing rural and underserved constituencies highlighted gaps in early diagnosis, overburdened health workers, and limited infrastructure--issues that could be effectively addressed through AI-enabled tools. By grounding the conversation in real, on-the-ground realities, the event demonstrated how healthcare AI, when responsibly integrated, could serve as a practical solution to systemic problems.
The gathering brought together prominent figures, including Members of Parliament Shri K. Francis George (Kottayam, Kerala), Shri Chatrapati Shahu Maharaj (Kolhapur, Maharashtra), and Shri Darshan Singh Chaudhary (Hoshangabad, Madhya Pradesh), as well as Shri Sudhaker Singh, former Agriculture Minister of Buxar, Bihar. Leaders from the global development sector--such as Mr. Harish Iyer (Gates Foundation), Dr. Jacob Creswell (Stop TB Partnership), Dr. Preet Deep Singh (APNA and Startup India), and Mr. Savio Rodrigues (founder, GoaChronicle)--also contributed to the discussion.
Key points raised during the roundtable included the growing burden on frontline health workers, delays in disease detection, and the lack of scalable diagnostic infrastructure, particularly in underserved regions. Several speakers highlighted the urgent need to integrate AI-driven tools into India's healthcare framework, especially for early diagnosis of tuberculosis and non-communicable diseases. Shri Darshan Singh Chaudhary delivered a compelling statement in Hindi, calling AI "the need of the hour" for rural healthcare and urging greater focus on its implementation in resource-constrained areas.
Though no formal partnerships were announced, the event generated substantial interest from Members of Parliament and senior officials to explore collaborative models with Qure.ai. Attendees conveyed support for future pilots and initiatives, recognising the company's potential to deliver meaningful outcomes across public health programmes.
"This roundtable was about action, not announcements," said Prashant Warier, CEO of Qure.ai. "The presence of such diverse and respected voices shows that the ecosystem is ready to move from intent to impact. We're focused on real-world use cases, grounded policy support, and long-term commitment. Responsible AI is no longer optional; it has to be part of the foundation."
Qure.ai, recently named to the TIME100 Most Influential Companies list for 2025, is the only Indian company to feature in this year's edition. With over 4,500 deployments across more than 100 countries, including 1,200 sites in 25 Indian states, its AI solutions are used daily in real-world clinical settings, whether in rural mobile screening vans or high-volume emergency departments.
The company's AI models, particularly those designed for chest X-ray interpretation, can detect conditions such as tuberculosis, lung nodules, lung cancer, heart failure and chronic obstructive pulmonary disease (COPD) within seconds. Qure's solutions have cleared findings and regulatory approvals in 92 countries.Qure's chest X-ray AI solution has been evaluated by the World Health Organization (WHO) and included in its policy guidance for tuberculosis screening, including in settings without access to a human reader.. In addition to diagnostics, Qure's large language model-powered tools are helping healthcare providers generate structured reports and digitise medical records--critical functions for consistent and responsive care delivery.
Qure's partnerships with AstraZeneca, Medtronic India, and Johnson & Johnson Medtech further demonstrate the platform's credibility and interoperability. These collaborations are not limited to product integration--they reflect the trust major Pharma and med-tech players place in Qure's technology and vision.
With its latest Series D funding, Qure.ai is focused on deepening its presence in settings where the impact is immediate, from government-run primary health centres to tertiary hospitals. The company's solutions are designed to work within existing clinical workflows, ensuring that innovation complements rather than disrupts care delivery.
The roundtable concluded on a strong note of alignment. Legislators, administrators, and public health experts echoed the belief that AI is not a futuristic add-on, but a present-day necessity to build more efficient, equitable, and scalable healthcare systems. The event has laid the groundwork for future collaborations, more policy engagement, and the continued recognition of Qure.ai as a quiet but essential partner in India's health innovation journey.
About Qure.ai
Qure.ai is a global health tech company that uses deep learning and Artificial Intelligence (AI) to make healthcare more accessible and equitable for patients worldwide. Qure's solutions power the efficient identification and management of Tuberculosis (TB), Lung Cancer and Neurocritical findings to support clinicians and propel developments in the pharmaceutical and medical device industries. The company empowers healthcare by helping to identify conditions fast, prioritize treatment planning and ultimately improve quality of patient life. Qure.ai has presence in over 100 countries, with regional offices in London and New York. The company is also part of the 2025 class of Time100 Most Influential Companies by Time Magazine.
(ADVERTORIAL DISCLAIMER: The above press release has been provided by VMPL. ANI will not be responsible in any way for the content of the same)
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
42 minutes ago
- Time of India
Neuroscientist says this one exercise could protect your brain and keep memory strong for years
Alzheimer's disease affects an estimated 6.7 million older adults in the United States, a figure expected to double by 2060. While there is currently no cure, research suggests that certain lifestyle habits can help reduce the risk, and one particular type of exercise appears to be especially effective. Independence Day 2025 Before Trump, British used tariffs to kill Indian textile Bank of Azad Hind: When Netaji gave India its own currency Swadeshi 2.0: India is no longer just a market, it's a maker Dementia remains one of the biggest global health challenges of the 21st century. Alzheimer's, the most common form, is a progressive and irreversible condition that causes functional, cognitive, and behavioural decline. Age and genetics are known risk factors, but studies have found that around 35% of dementia risk is linked to modifiable factors such as high blood pressure in midlife, obesity, smoking, social isolation, hearing loss, depression, diabetes, and low physical activity. The Exercise That Stands Out Physical activity has long been recognised as a protective factor for brain health. However, according to a report in TOI, new research points towards a specific approach that may offer even greater benefits, dual-task exercise. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Undo Dr Robert W.B. Love, a neuroscientist specialising in Alzheimer's prevention, was quoted in TOI highlighting that this type of exercise involves engaging both the body and the mind at the same time. Dr Heather Sandison, a naturopathic doctor, was quoted as explaining in TOI that dual-task exercise means 'doing something physical while also challenging the brain', for example, walking while having a conversation. What Research Reveals A 2022 review, published in the Journal of Alzheimer's Disease and cited by TOI, examined how dual-task training, activities combining physical movement with mental challenges, affected older adults with cognitive decline. The review found that 2–5 weekly sessions, each lasting between 30 and 120 minutes, led to noticeable improvements in memory, attention, problem-solving, balance, and walking speed. Live Events The researchers also noted a surprising benefit: reduced levels of ß-amyloid, a protein linked to Alzheimer's disease. As reported in TOI, this is because dual-task activities require the brain to process information, coordinate movement, and maintain focus all at once. This simultaneous demand engages multiple brain networks, strengthens neural connections, and promotes neuroplasticity, the brain's ability to adapt and form new pathways. No Single Solution Experts emphasised, as reported in TOI, that no single habit can guarantee protection against Alzheimer's. The most effective strategy combines regular dual-task exercise with other healthy lifestyle choices, such as a balanced diet, staying socially engaged, and managing health conditions like hypertension and diabetes. The message is clear: while there is no magic bullet for preventing Alzheimer's, combining mental and physical stimulation through dual-task activities could be a valuable tool in preserving both cognitive skills and independence in later life.


Business Standard
2 hours ago
- Business Standard
CK Birla Hospitals, Jaipur deepens public health role with sustained community outreach in Rajasthan
VMPL Jaipur (Rajasthan) [India], August 14: In a city where non-communicable diseases are steadily rising and awareness often trails behind medical need, CK Birla Hospitals, Jaipur, appears to be quietly reshaping how healthcare engages with the public -- not just inside its ICUs and operating rooms, but also out in parks, auditoriums, school halls, and local radio airwaves. Over the past six months, the hospital has broadened its footprint beyond clinical care, running a range of initiatives aimed at preventive health, early diagnosis, and everyday well-being -- part of a growing shift in India's private healthcare space toward more sustained community engagement. From holding free health camps and community talks to creating localised radio campaigns in Hindi, the hospital's approach has leaned less on large-scale media spends and more on person-to-person contact -- meeting people where they are, whether that's in pensioner colonies, office canteens, or early morning walkers' groups. Building awareness, bit by bit Over 40 community health talks have been conducted in the last half-year alone, and hospital data shows that many of them were at RWAs, PSU offices, schools, and small businesses. Topics included the early warning signs of cardiac issues, understanding lifestyle-related cancers, and demystifying lesser-understood concerns like sleep apnea etc. Doctors conducting these sessions take questions directly from participants, many of whom may not have visited a hospital before. Many of the talks are timed with relevant global or national health days, which adds context and makes it easier to draw attention. On World Cancer Day and Mother's Day, for instance, awareness sessions focused on women's health, breast cancer myths, and the importance of preventive health checks. Health messaging on air In a state where local radio remains an influential medium for daily information, the hospital has used on-air campaigns to widen its message. On radio, CK Birla Hospitals, Jaipur ran a liver health series titled "Jaani Liver", aimed at educating listeners on fatty liver, hepatitis, and alcohol-related damage. Another programme, "Kidney Ka RJ", took on the growing issue of chronic kidney disease -- a condition that often goes undetected in its early stages. The tone across these shows was conversational, not clinical, blending basic education with real-life scenarios. One of the more hard-hitting campaigns was "Dhuandhaar Paari Ki Samaapti" -- a tobacco cessation series designed to coincide with No Tobacco Day. Through short episodes and interviews, the campaign focused on both the physical and emotional effects of tobacco use, and the support available for those trying to quit. These efforts, though not new, reflect a more consistent and hyperlocal model of outreach -- one the local community has begun to notice. Prevention on the ground The hospital's preventive care push has also included a series of free health camps. In over 25 locations across Jaipur and surrounding areas, medical teams have provided basic screenings -- for blood pressure, blood sugar, BMI, and in some cases, ECGs and liver/kidney function checks. Such camps serve two purposes: offering low-barrier access to initial screening, and encouraging attendees to follow up with regular medical care. On the environmental front, CK Birla Hospitals, Jaipur marked World Environment Day with a sapling plantation drive and distribution of reusable cotton bags. The message was simple but relevant: public health and environmental health are increasingly interlinked. The hospital also organised a walkathon to promote the benefits of regular physical activity. In another effort tied to World Yoga Day, it hosted a 7-day yoga event across city parks, community spaces, and the hospital campus, drawing participation from over 2,500 people -- ranging from students to senior citizens. Looking ahead: a community run for heart health Later this year, on September 21, the hospital will conduct the third edition of its flagship public health event -- Run for Heart, held in observance of World Heart Day. The event, which draws over a thousand participants annually, is expected to feature three categories: a 3 km fun run, and 5 km and 10 km timed runs. Shaping perception, slowly but steadily While public-private partnerships and policy-level interventions often dominate headlines, much of the slow, grassroots-level shift in health awareness tends to happen through quieter efforts like these -- layered over time, embedded in local culture, and shaped more by trust than by branding. In Jaipur, where access to modern healthcare has improved but awareness gaps still persist, particularly in preventive care and early diagnosis, CK Birla Hospital's approach may be helping narrow the divide. Technology driving advanced care Alongside its community initiatives, CK Birla Hospitals, Jaipur continues to strengthen its role as a centre for advanced medical technology. The hospital offers high-end robotic surgery for soft tissue procedures in gynaecology, urology, and general surgery, performed by an experienced team of specialists. These robotic-assisted procedures are minimally invasive and highly precise, offering significant patient benefits such as minimal blood loss, reduced post-operative pain and discomfort, shorter hospital stays, and faster recovery times -- helping patients return to their daily lives sooner.


NDTV
2 hours ago
- NDTV
Global First: Indian Scientists Map Cervical Cancer At Molecular Level, Open Doors To Precision Treatment
In a landmark achievement that places India firmly on the global oncology map, a team of Indian scientists and clinicians has conducted the country's first-ever integrative genomic and phosphoproteomic analysis of cervical cancer. This pioneering research, based on patient samples from Bihar, a state heavily impacted by the disease, unravels why some patients fail to respond to standard treatments and suggests more effective, personalised alternatives. Led by PhD scholars Janani Sambath and Irene A. George under the mentorship of Dr. Prashant Kumar, this study represents the world's first whole-genome and global proteomics-phosphoproteomics mapping of cervical cancer. On the clinical front, Dr. Richa Chauhan, senior oncologist at Mahavir Cancer Sansthan, Patna, monitored the application of these findings in real-world scenarios. "This research is close to my heart," says Dr. Chauhan. "As a cancer physician, I see women every day, many from rural or underserved backgrounds, with late-stage cervical cancer. Being part of a study that not only decodes resistance but also proposes actionable solutions is deeply gratifying." Revealing The Genetic Drivers Of Resistance Using advanced DNA sequencing, the researchers identified two major genetic alterations common in treatment-resistant cervical tumours: An increase in the number of copies of the EGFR gene, which accelerates cancer cell growth and spread. The loss of the STK11 gene, which normally functions as a growth brake. These findings are clinically significant as EGFR can be targeted using existing cancer drugs, potentially offering life-saving treatment options for patients unresponsive to standard therapy. Proteins That Hold The Key The proteomics arm of the study revealed that the CSNK2A1 protein acts as a "master switch" in treatment-resistant tumours, enabling survival pathways. Blocking this protein with the drug silmitasertib, in combination with low-dose cisplatin, significantly reduced cancer growth in lab experiments. In parallel, the phosphoproteomics analysis uncovered another protein-STX3-consistently present at high levels in resistant tumours. Identified as a powerful biomarker, STX3's discovery has been patented by the Government of India (Patent No. 404113) and has garnered widespread national attention. Recognition On The Global Stage Dr. Prashant Kumar presented the study at the ESMO Asia Congress 2024 in Singapore, where it earned the prestigious Best Poster Award, competing against top cancer research teams worldwide. This recognition not only validates the scientific excellence of the work but also strengthens India's position in the fight against women's cancers. "This is not just a scientific achievement, it's a social imperative," says Dr. Kumar. "We're proud that our research, powered by Indian samples and minds, is creating real translational possibilities." Why It Matters For India: Cervical Cancer Impact On Indian Women Cervical cancer is the second most common cancer among Indian women, responsible for nearly 10% of all female cancer cases. Despite HPV vaccination efforts, rural states like Bihar continue to face late-stage diagnoses, underscoring the urgent need for early detection tools and improved treatment protocols. Cervical cancer begins in the cervix-the lower part of the uterus-and is typically driven by long-term infection with high-risk human papillomavirus (HPV) types, especially HPV-16 and 18. Often slow to show symptoms, it may initially involve irregular or abnormal vaginal bleeding, making regular screening (via Pap smears or HPV tests) vital for early detection and successful treatment. Globally, it ranks as the fourth most common cancer in women, with over 600,000 new cases and nearly 342,000 deaths reported in 2020. In India, the burden is even higher: age-standardised incidence is about 14.7 per 100,000 women, with a mortality rate of 9.2 per 100,000, as another study published in BMC Cancer in 2022 suggests. Roughly 96,900 new cases are diagnosed annually, with 60,000-67,000 deaths, accounting for about one-fifth of global cervical cancer burden. The five-year survival rate in India hovers around 47%, significantly lower than figures in more developed countries. Vulnerable groups, such as women from lower socioeconomic strata, rural areas, and with limited education, are disproportionately affected. Incidence rates peak among women aged 50-59, especially in regions like Northeast India, with cities like Aizawl reporting rates as high as 24 per 100,000. Alarmingly, screening rates remain abysmally low. Data from NFHS-5 shows only about 1-2% of women have ever undergone cervical cancer screening. This wide gap in awareness and access underscores a pressing public health priority. Keeping these in mind, the team behind the new breakthrough study aims to move silmitasertib-based combination regimens into clinical trials, alongside the development of targeted clinical tests to guide treatment planning. With its blend of cutting-edge molecular science and deep compassion for patients, this research offers renewed hope to thousands of women who need it most.